Tapewire

Nasdaq · USD

ZS

Zscaler, Inc.

Export transactions ↓
Tapewire entity
3153
SEC CIK
0001713683
Parsed reports
547

Last 12 months

Inside the activity.

0 purchase rows · 65 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202509
Jan 202601
Feb 202600
Mar 202608
Apr 202600
May 202600
Jun 2026012
Jul 202606
Aug 202605
Sep 2026021
Oct 202603

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 12, 2020 Filed May 13, 2020 21:55 UTC
Sinha AmitDirector · President of R&D and CTO
SaleCommon Stock 2,254 $77.57 $174,849.09
Disclosure

SEC source: 0001713683-20-000073 · wf-form4_158940689544726.xml · nonDerivative · entry 3

Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 125,469

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on June 28, 2019.

F3 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $76.97 to $77.96

Read SEC document
May 12, 2020 Filed May 13, 2020 21:55 UTC
Sinha AmitDirector · President of R&D and CTO
SaleCommon Stock 1,049 $76.40 $80,143.18
Disclosure

SEC source: 0001713683-20-000073 · wf-form4_158940689544726.xml · nonDerivative · entry 2

Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 127,723

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on June 28, 2019.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.88 to $76.84, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4.

Read SEC document
May 12, 2020 Filed May 13, 2020 21:55 UTC
Sinha AmitDirector · President of R&D and CTO
Exercise / conversionCommon Stock 4,000 $5.93 $23,700.00
Disclosure

SEC source: 0001713683-20-000073 · wf-form4_158940689544726.xml · nonDerivative · entry 1

Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 128,772

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 08, 2020 Filed May 11, 2020 20:27 UTC
Schlossman RobertChief Legal Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 10,900 $0.00 Strike: $4.40 $0.00
Disclosure

SEC source: 0001713683-20-000071 · wf-form4_158922881634683.xml · derivative · entry 6

Schlossman Robert · CIK 0001435941 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 131,000

Underlying: Common Stock · 10,900 shares

Expires 2023-01-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The option is subject to an early exercise provision and is immediately exercisable. One-fourth of the shares subject to the option vested on January 14, 2017 and 1/48 of the shares vest monthly thereafter.

Read SEC document
May 08, 2020 Filed May 11, 2020 20:27 UTC
Schlossman RobertChief Legal Officer
SaleCommon Stock 10,900 $75.09 $818,512.61
Disclosure

SEC source: 0001713683-20-000071 · wf-form4_158922881634683.xml · nonDerivative · entry 4

Schlossman Robert · CIK 0001435941 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 89,060

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on June 27, 2019.

F3 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $75.00 to $75.2750.

Read SEC document
May 08, 2020 Filed May 11, 2020 20:27 UTC
Schlossman RobertChief Legal Officer
Exercise / conversionCommon Stock 10,900 $4.40 $47,960.00
Disclosure

SEC source: 0001713683-20-000071 · wf-form4_158922881634683.xml · nonDerivative · entry 3

Schlossman Robert · CIK 0001435941 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 99,960

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 07, 2020 Filed May 11, 2020 20:27 UTC
Schlossman RobertChief Legal Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 4,100 $0.00 Strike: $4.40 $0.00
Disclosure

SEC source: 0001713683-20-000071 · wf-form4_158922881634683.xml · derivative · entry 5

Schlossman Robert · CIK 0001435941 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 141,900

Underlying: Common Stock · 4,100 shares

Expires 2023-01-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The option is subject to an early exercise provision and is immediately exercisable. One-fourth of the shares subject to the option vested on January 14, 2017 and 1/48 of the shares vest monthly thereafter.

Read SEC document
May 07, 2020 Filed May 11, 2020 20:27 UTC
Schlossman RobertChief Legal Officer
SaleCommon Stock 4,100 $75.07 $307,802.99
Disclosure

SEC source: 0001713683-20-000071 · wf-form4_158922881634683.xml · nonDerivative · entry 2

Schlossman Robert · CIK 0001435941 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 89,060

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on June 27, 2019.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.00 to $75.15, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.

Read SEC document
May 07, 2020 Filed May 11, 2020 20:27 UTC
Schlossman RobertChief Legal Officer
Exercise / conversionCommon Stock 4,100 $4.40 $18,040.00
Disclosure

SEC source: 0001713683-20-000071 · wf-form4_158922881634683.xml · nonDerivative · entry 1

Schlossman Robert · CIK 0001435941 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 93,160

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 07, 2020 Filed May 11, 2020 20:26 UTC SaleCommon Stock 2,100 $75.00 $157,500.00
Disclosure

SEC source: 0001713683-20-000070 · wf-form4_158922879249562.xml · nonDerivative · entry 1

Brown Andrew William Fraser · CIK 0001593803 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 39,013

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on March 5, 2019, as amended December 31, 2019.

F2 · ownership.nature: The shares are held of record by the Andrew W.F. Brown 2017 Grantor Retained Annuity Trust for which the reporting person's spouse serves as a trustee.

Read SEC document
May 05, 2020 Filed May 6, 2020 20:27 UTC
Sinha AmitDirector · President of R&D and CTO
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 7,351 $0.00 Strike: $5.93 $0.00
Disclosure

SEC source: 0001713683-20-000067 · wf-form4_158879682059944.xml · derivative · entry 6

Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 254,666

Underlying: Common Stock · 7,351 shares

Expires 2027-04-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: One-fourth of the shares subject to the option vest on November 1, 2018 and 1/48 of the shares vest monthly thereafter.

Read SEC document
May 05, 2020 Filed May 6, 2020 20:27 UTC
Sinha AmitDirector · President of R&D and CTO
SaleCommon Stock 3,105 $71.31 $221,409.17
Disclosure

SEC source: 0001713683-20-000067 · wf-form4_158879682059944.xml · nonDerivative · entry 3

Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 124,772

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on June 28, 2019.

F3 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $71.00 to $71.61.

Read SEC document
May 05, 2020 Filed May 6, 2020 20:27 UTC
Sinha AmitDirector · President of R&D and CTO
SaleCommon Stock 4,246 $70.66 $300,015.99
Disclosure

SEC source: 0001713683-20-000067 · wf-form4_158879682059944.xml · nonDerivative · entry 2

Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 127,877

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on June 28, 2019.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.00 to $70.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.

Read SEC document
May 05, 2020 Filed May 6, 2020 20:27 UTC
Sinha AmitDirector · President of R&D and CTO
Exercise / conversionCommon Stock 7,351 $5.93 $43,554.68
Disclosure

SEC source: 0001713683-20-000067 · wf-form4_158879682059944.xml · nonDerivative · entry 1

Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 132,123

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 01, 2020 Filed May 1, 2020 23:32 UTC
Schlossman RobertChief Legal Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 2,000 $0.00 Strike: $4.40 $0.00
Disclosure

SEC source: 0001713683-20-000065 · wf-form4_158837594975782.xml · derivative · entry 4

Schlossman Robert · CIK 0001435941 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 146,000

Underlying: Common Stock · 2,000 shares

Expires 2023-01-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The option is subject to an early exercise provision and is immediately exercisable. One-fourth of the shares subject to the option vested on January 14, 2017 and 1/48 of the shares vest monthly thereafter.

Read SEC document
May 01, 2020 Filed May 1, 2020 23:32 UTC
Schlossman RobertChief Legal Officer
SaleCommon Stock 400 $66.86 $26,742.24
Disclosure

SEC source: 0001713683-20-000065 · wf-form4_158837594975782.xml · nonDerivative · entry 3

Schlossman Robert · CIK 0001435941 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 89,060

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on June 27, 2019.

F3 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $66.76 to $67.08.

Read SEC document
May 01, 2020 Filed May 1, 2020 23:32 UTC
Schlossman RobertChief Legal Officer
SaleCommon Stock 1,600 $66.25 $106,000.00
Disclosure

SEC source: 0001713683-20-000065 · wf-form4_158837594975782.xml · nonDerivative · entry 2

Schlossman Robert · CIK 0001435941 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 89,460

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on June 27, 2019.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.74 to $66.73, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.

Read SEC document
May 01, 2020 Filed May 1, 2020 23:32 UTC
Schlossman RobertChief Legal Officer
Exercise / conversionCommon Stock 2,000 $4.40 $8,800.00
Disclosure

SEC source: 0001713683-20-000065 · wf-form4_158837594975782.xml · nonDerivative · entry 1

Schlossman Robert · CIK 0001435941 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 91,060

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 28, 2020 Filed Apr 29, 2020 00:36 UTC
Sinha AmitDirector · President of R&D and CTO
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 649 $0.00 Strike: $5.93 $0.00
Disclosure

SEC source: 0001713683-20-000063 · wf-form4_158812055901135.xml · derivative · entry 9

Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 262,017

Underlying: Common Stock · 649 shares

Expires 2027-04-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: One-fourth of the shares subject to the option vest on November 1, 2018 and 1/48 of the shares vest monthly thereafter.

Read SEC document
April 28, 2020 Filed Apr 29, 2020 00:36 UTC
Sinha AmitDirector · President of R&D and CTO
SaleCommon Stock 649 $70.86 $45,987.04
Disclosure

SEC source: 0001713683-20-000063 · wf-form4_158812055901135.xml · nonDerivative · entry 5

Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 124,772

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on June 28, 2019.

F4 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $70.22 to $71.10.

Read SEC document
April 28, 2020 Filed Apr 29, 2020 00:36 UTC
Sinha AmitDirector · President of R&D and CTO
Exercise / conversionCommon Stock 649 $5.93 $3,845.33
Disclosure

SEC source: 0001713683-20-000063 · wf-form4_158812055901135.xml · nonDerivative · entry 4

Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 125,421

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 27, 2020 Filed Apr 29, 2020 00:36 UTC
Sinha AmitDirector · President of R&D and CTO
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 3,255 $0.00 Strike: $5.93 $0.00
Disclosure

SEC source: 0001713683-20-000063 · wf-form4_158812055901135.xml · derivative · entry 8

Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 262,666

Underlying: Common Stock · 3,255 shares

Expires 2027-04-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: One-fourth of the shares subject to the option vest on November 1, 2018 and 1/48 of the shares vest monthly thereafter.

Read SEC document
April 27, 2020 Filed Apr 29, 2020 00:36 UTC
Sinha AmitDirector · President of R&D and CTO
SaleCommon Stock 308 $71.11 $21,901.33
Disclosure

SEC source: 0001713683-20-000063 · wf-form4_158812055901135.xml · nonDerivative · entry 3

Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 124,772

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on June 28, 2019.

F3 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $71.00 to $71.27.

Read SEC document
April 27, 2020 Filed Apr 29, 2020 00:36 UTC
Sinha AmitDirector · President of R&D and CTO
SaleCommon Stock 2,947 $70.58 $207,994.25
Disclosure

SEC source: 0001713683-20-000063 · wf-form4_158812055901135.xml · nonDerivative · entry 2

Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 125,080

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on June 28, 2019.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.00 to $70.97, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.

Read SEC document
April 27, 2020 Filed Apr 29, 2020 00:36 UTC
Sinha AmitDirector · President of R&D and CTO
Exercise / conversionCommon Stock 3,255 $5.93 $19,285.88
Disclosure

SEC source: 0001713683-20-000063 · wf-form4_158812055901135.xml · nonDerivative · entry 1

Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 128,027

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 21, 2020 Filed Apr 22, 2020 21:48 UTC
Sinha AmitDirector · President of R&D and CTO
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 745 $0.00 Strike: $5.93 $0.00
Disclosure

SEC source: 0001713683-20-000061 · wf-form4_158759211661577.xml · derivative · entry 5

Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 265,921

Underlying: Common Stock · 745 shares

Expires 2027-04-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: One-fourth of the shares subject to the option vest on November 1, 2018 and 1/48 of the shares vest monthly thereafter.

Read SEC document
April 21, 2020 Filed Apr 22, 2020 21:48 UTC
Sinha AmitDirector · President of R&D and CTO
SaleCommon Stock 745 $70.24 $52,327.09
Disclosure

SEC source: 0001713683-20-000061 · wf-form4_158759211661577.xml · nonDerivative · entry 2

Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 124,772

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on June 29, 2018.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.04 to $70.78, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 21, 2020 Filed Apr 22, 2020 21:48 UTC
Sinha AmitDirector · President of R&D and CTO
Exercise / conversionCommon Stock 745 $5.93 $4,414.13
Disclosure

SEC source: 0001713683-20-000061 · wf-form4_158759211661577.xml · nonDerivative · entry 1

Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 125,517

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 16, 2020 Filed Apr 17, 2020 00:04 UTC
Schlossman RobertChief Legal Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 1,659 $0.00 Strike: $4.40 $0.00
Disclosure

SEC source: 0001713683-20-000058 · wf-form4_158708186351573.xml · derivative · entry 6

Schlossman Robert · CIK 0001435941 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 148,000

Underlying: Common Stock · 1,659 shares

Expires 2023-01-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option is subject to an early exercise provision and is immediately exercisable. One-fourth of the shares subject to the option vested on January 14, 2017 and 1/48 of the shares vest monthly thereafter.

Read SEC document
April 16, 2020 Filed Apr 17, 2020 00:04 UTC
Schlossman RobertChief Legal Officer
SaleCommon Stock 1,659 $70.55 $117,042.45
Disclosure

SEC source: 0001713683-20-000058 · wf-form4_158708186351573.xml · nonDerivative · entry 4

Schlossman Robert · CIK 0001435941 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 89,060

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on June 27, 2019.

Read SEC document
April 16, 2020 Filed Apr 17, 2020 00:04 UTC
Schlossman RobertChief Legal Officer
Exercise / conversionCommon Stock 1,659 $4.40 $7,299.60
Disclosure

SEC source: 0001713683-20-000058 · wf-form4_158708186351573.xml · nonDerivative · entry 3

Schlossman Robert · CIK 0001435941 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,719

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 16, 2020 Filed Apr 17, 2020 00:05 UTC
Sinha AmitDirector · President of R&D and CTO
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 11,609 $0.00 Strike: $5.93 $0.00
Disclosure

SEC source: 0001713683-20-000059 · wf-form4_158708188587248.xml · derivative · entry 11

Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 266,666

Underlying: Common Stock · 11,609 shares

Expires 2027-04-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F9 · derivative.exercise_date: One-fourth of the shares subject to the option vest on November 1, 2018 and 1/48 of the shares vest monthly thereafter.

Read SEC document
April 16, 2020 Filed Apr 17, 2020 00:05 UTC
Sinha AmitDirector · President of R&D and CTO
SaleCommon Stock 755 $73.37 $55,395.71
Disclosure

SEC source: 0001713683-20-000059 · wf-form4_158708188587248.xml · nonDerivative · entry 7

Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 124,772

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on June 28, 2019.

F6 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $73.23 to $73.60.

Read SEC document
April 16, 2020 Filed Apr 17, 2020 00:05 UTC
Sinha AmitDirector · President of R&D and CTO
SaleCommon Stock 3,094 $72.66 $224,814.68
Disclosure

SEC source: 0001713683-20-000059 · wf-form4_158708188587248.xml · nonDerivative · entry 6

Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 125,527

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on June 28, 2019.

F5 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $72.23 to $73.22.

Read SEC document
April 16, 2020 Filed Apr 17, 2020 00:05 UTC
Sinha AmitDirector · President of R&D and CTO
SaleCommon Stock 2,059 $71.70 $147,638.74
Disclosure

SEC source: 0001713683-20-000059 · wf-form4_158708188587248.xml · nonDerivative · entry 5

Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 128,621

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on June 28, 2019.

F4 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $71.23 to $72.22.

Read SEC document
April 16, 2020 Filed Apr 17, 2020 00:05 UTC
Sinha AmitDirector · President of R&D and CTO
SaleCommon Stock 5,701 $70.68 $402,957.51
Disclosure

SEC source: 0001713683-20-000059 · wf-form4_158708188587248.xml · nonDerivative · entry 4

Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 130,680

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on June 28, 2019.

F3 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $70.23 to $71.22.

Read SEC document
April 16, 2020 Filed Apr 17, 2020 00:05 UTC
Sinha AmitDirector · President of R&D and CTO
Exercise / conversionCommon Stock 11,609 $5.93 $68,783.33
Disclosure

SEC source: 0001713683-20-000059 · wf-form4_158708188587248.xml · nonDerivative · entry 3

Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 136,381

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 15, 2020 Filed Apr 17, 2020 00:04 UTC
Schlossman RobertChief Legal Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 13,341 $0.00 Strike: $4.40 $0.00
Disclosure

SEC source: 0001713683-20-000058 · wf-form4_158708186351573.xml · derivative · entry 5

Schlossman Robert · CIK 0001435941 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 149,659

Underlying: Common Stock · 13,341 shares

Expires 2023-01-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option is subject to an early exercise provision and is immediately exercisable. One-fourth of the shares subject to the option vested on January 14, 2017 and 1/48 of the shares vest monthly thereafter.

Read SEC document
April 15, 2020 Filed Apr 17, 2020 00:04 UTC
Schlossman RobertChief Legal Officer
SaleCommon Stock 13,341 $70.01 $933,974.06
Disclosure

SEC source: 0001713683-20-000058 · wf-form4_158708186351573.xml · nonDerivative · entry 2

Schlossman Robert · CIK 0001435941 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 89,060

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on June 27, 2019.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.00 to $70.05, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 15, 2020 Filed Apr 17, 2020 00:04 UTC
Schlossman RobertChief Legal Officer
Exercise / conversionCommon Stock 13,341 $4.40 $58,700.40
Disclosure

SEC source: 0001713683-20-000058 · wf-form4_158708186351573.xml · nonDerivative · entry 1

Schlossman Robert · CIK 0001435941 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 102,401

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 15, 2020 Filed Apr 17, 2020 00:05 UTC
Sinha AmitDirector · President of R&D and CTO
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 55,058 $0.00 Strike: $5.93 $0.00
Disclosure

SEC source: 0001713683-20-000059 · wf-form4_158708188587248.xml · derivative · entry 10

Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 278,275

Underlying: Common Stock · 55,058 shares

Expires 2027-04-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F9 · derivative.exercise_date: One-fourth of the shares subject to the option vest on November 1, 2018 and 1/48 of the shares vest monthly thereafter.

Read SEC document
April 15, 2020 Filed Apr 17, 2020 00:05 UTC
Sinha AmitDirector · President of R&D and CTO
SaleCommon Stock 55,058 $70.00 $3,854,269.22
Disclosure

SEC source: 0001713683-20-000059 · wf-form4_158708188587248.xml · nonDerivative · entry 2

Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 124,772

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on June 28, 2019.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.00 to $70.07, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (4) to this Form 4.

Read SEC document
April 15, 2020 Filed Apr 17, 2020 00:05 UTC
Sinha AmitDirector · President of R&D and CTO
Exercise / conversionCommon Stock 55,058 $5.93 $326,218.65
Disclosure

SEC source: 0001713683-20-000059 · wf-form4_158708188587248.xml · nonDerivative · entry 1

Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 179,830

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 09, 2020 Filed Apr 9, 2020 18:39 UTC
CANESSA REMOChief Financial Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 108,694 $0.00 Strike: $5.82 $0.00
Disclosure

SEC source: 0001713683-20-000055 · wf-form4_158647198226164.xml · derivative · entry 6

CANESSA REMO · CIK 0001250311 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 310,000

Underlying: Common Stock · 108,694 shares

Expires 2027-03-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option is subject to an early exercise provision and is immediately exercisable. One-fourth of the shares subject to the option vested on February 6, 2018 and 1/48 of the shares vest monthly thereafter.

Read SEC document
April 09, 2020 Filed Apr 9, 2020 18:39 UTC
CANESSA REMOChief Financial Officer
Exercise / conversionCommon Stock 108,694 $5.82 $632,599.08
Disclosure

SEC source: 0001713683-20-000055 · wf-form4_158647198226164.xml · nonDerivative · entry 3

CANESSA REMO · CIK 0001250311 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 418,067

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 08, 2020 Filed Apr 9, 2020 18:39 UTC
CANESSA REMOChief Financial Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 1,306 $0.00 Strike: $5.82 $0.00
Disclosure

SEC source: 0001713683-20-000055 · wf-form4_158647198226164.xml · derivative · entry 5

CANESSA REMO · CIK 0001250311 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 418,694

Underlying: Common Stock · 1,306 shares

Expires 2027-03-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option is subject to an early exercise provision and is immediately exercisable. One-fourth of the shares subject to the option vested on February 6, 2018 and 1/48 of the shares vest monthly thereafter.

Read SEC document
April 08, 2020 Filed Apr 9, 2020 18:39 UTC
CANESSA REMOChief Financial Officer
SaleCommon Stock 108,694 $65.00 $7,065,110.00
Disclosure

SEC source: 0001713683-20-000055 · wf-form4_158647198226164.xml · nonDerivative · entry 4

CANESSA REMO · CIK 0001250311 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 309,373

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on March 29, 2019.

Read SEC document
April 08, 2020 Filed Apr 9, 2020 18:39 UTC
CANESSA REMOChief Financial Officer
SaleCommon Stock 1,306 $65.00 $84,890.00
Disclosure

SEC source: 0001713683-20-000055 · wf-form4_158647198226164.xml · nonDerivative · entry 2

CANESSA REMO · CIK 0001250311 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 309,373

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on March 29, 2019.

Read SEC document
April 08, 2020 Filed Apr 9, 2020 18:39 UTC
CANESSA REMOChief Financial Officer
Exercise / conversionCommon Stock 1,306 $5.82 $7,600.92
Disclosure

SEC source: 0001713683-20-000055 · wf-form4_158647198226164.xml · nonDerivative · entry 1

CANESSA REMO · CIK 0001250311 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 310,679

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 01, 2020 Filed Apr 3, 2020 00:11 UTC
Schlossman RobertChief Legal Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 2,000 $0.00 Strike: $4.40 $0.00
Disclosure

SEC source: 0001713683-20-000051 · wf-form4_158587264296412.xml · derivative · entry 7

Schlossman Robert · CIK 0001435941 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 163,000

Underlying: Common Stock · 2,000 shares

Expires 2023-01-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: The option is subject to an early exercise provision and is immediately exercisable. One-fourth of the shares subject to the option vested on January 14, 2017 and 1/48 of the shares vest monthly thereafter.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.